Johnsons & Johnson Medical Devices (JJMD) launched CareAdvantage, a new approach to assist in driving value-based healthcare in hospitals across Europe, Middle East, and Africa (EMEA). The approach is holistic and driven by data.
The healthcare market is changing, with pressure to meet the “triple aim” of improving outcomes, increase patient satisfaction, and reduce costs. The focus is shifting from volume to value; therefore, there is a growing need for new delivery models, resulting in rapid transformation for hospital systems, clinicians, and their patients.
CareAdvantage focuses on four areas-improving the patient experience, driving supply chain efficiencies, building clinical partnerships, and providing commercial support.
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.